AAAAAA

   
Results: 1-12 |
Results: 12
PREDISPOSITION TO ESSENTIAL-HYPERTENSION AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN IDDM PATIENTS
Authors: FAGERUDD JA TARNOW L JACOBSEN P STENMAN S NIELSEN FS PETTERSSONFERNHOLM KJ GRONHAGENRISKA C PARVING HH GROOP PH
Citation: Ja. Fagerudd et al., PREDISPOSITION TO ESSENTIAL-HYPERTENSION AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN IDDM PATIENTS, Diabetes, 47(3), 1998, pp. 439-444
PREDISPOSITION TO HYPERTENSION AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN DDM PATIENTS
Authors: FAGERUDD J TARNOW L JACOBSEN P STENMAN S NIELSEN FS PETTERSSONFERNHOLM K GRONHAGENRISKA C PARVING HH GROOP PH
Citation: J. Fagerudd et al., PREDISPOSITION TO HYPERTENSION AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN DDM PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 525-525
SYMPTOMS AND DIFFERENTIAL-DIAGNOSIS OF PATIENTS FEARING MERCURY TOXICITY FROM AMALGAM FILLINGS
Authors: STENMAN S GRANS L
Citation: S. Stenman et L. Grans, SYMPTOMS AND DIFFERENTIAL-DIAGNOSIS OF PATIENTS FEARING MERCURY TOXICITY FROM AMALGAM FILLINGS, Scandinavian journal of work, environment & health, 23, 1997, pp. 59-63
ON THE NATURE AND ORIGIN OF PSYCHOSOMATIC SYMPTOMS
Authors: SHORTER E KLEIN G STENMAN S LEVI L BOSTROM H LAMBERG BA WESSELY S MALT U FORD CW
Citation: E. Shorter et al., ON THE NATURE AND ORIGIN OF PSYCHOSOMATIC SYMPTOMS, Scandinavian journal of work, environment & health, 23, 1997, pp. 105-112
INCIDENCE OF UREMIC NEPHROPATHY IN IDDM IN FINLAND
Authors: GRONHAGENRISKA C REUNANEN A SAHIPAKKA K STENMAN S
Citation: C. Gronhagenriska et al., INCIDENCE OF UREMIC NEPHROPATHY IN IDDM IN FINLAND, Diabetologia, 40, 1997, pp. 2110-2110
OUTCOME OF UREMIC NEPHROPATHY IN IDDM IN FINLAND
Authors: GRONHAGENRISKA C STENMAN S
Citation: C. Gronhagenriska et S. Stenman, OUTCOME OF UREMIC NEPHROPATHY IN IDDM IN FINLAND, Diabetologia, 40, 1997, pp. 2112-2112
CARDIOVASCULAR COMPLICATIONS AND RENAL-DISEASE
Authors: GRONHAGENRISKA C FAGERUDD J GROOP PH METSARINNE K STENMAN S TOTTERMAN K
Citation: C. Gronhagenriska et al., CARDIOVASCULAR COMPLICATIONS AND RENAL-DISEASE, Kidney international, 49(3), 1996, pp. 919-919
HIGH-FREQUENCY OF SILENT INFLAMMATORY BOWEL-DISEASE IN SPONDYLARTHROPATHY
Authors: LEIRISALOREPO M TURUNEN U STENMAN S HELENIUS P SEPPALA K
Citation: M. Leirisalorepo et al., HIGH-FREQUENCY OF SILENT INFLAMMATORY BOWEL-DISEASE IN SPONDYLARTHROPATHY, Arthritis and rheumatism, 37(1), 1994, pp. 23-31
CONCENTRATIONS OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR (PSTI), ACUTE-PHASE PROTEINS, AND NEOPTERIN IN CROHNS-DISEASE - COMPARISON WITH CLINICAL-DISEASE ACTIVITY AND ENDOSCOPIC FINDINGS
Authors: HALME L VONSMITTEN K STENMAN S TURPEINEN U STENMAN UH
Citation: L. Halme et al., CONCENTRATIONS OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR (PSTI), ACUTE-PHASE PROTEINS, AND NEOPTERIN IN CROHNS-DISEASE - COMPARISON WITH CLINICAL-DISEASE ACTIVITY AND ENDOSCOPIC FINDINGS, Scandinavian journal of clinical & laboratory investigation, 53(4), 1993, pp. 359-366
RELATIONSHIP BETWEEN CARBOHYDRATE-METABOLISM AND SERUM INSULIN-LIKE GROWTH-FACTOR SYSTEM IN POSTMENOPAUSAL WOMEN - COMPARISON OF ENDOMETRIAL CANCER-PATIENTS WITH HEALTHY CONTROLS
Authors: RUTANEN EM STENMAN S BLUM W KARKKAINEN T LEHTOVIRTA P STENMAN UH
Citation: Em. Rutanen et al., RELATIONSHIP BETWEEN CARBOHYDRATE-METABOLISM AND SERUM INSULIN-LIKE GROWTH-FACTOR SYSTEM IN POSTMENOPAUSAL WOMEN - COMPARISON OF ENDOMETRIAL CANCER-PATIENTS WITH HEALTHY CONTROLS, The Journal of clinical endocrinology and metabolism, 77(1), 1993, pp. 199-204
THE BENEFIT OF INCREASING SULFONYLUREA DOSE - RESPONSE
Authors: GROOP L STENMAN S GROOP PH
Citation: L. Groop et al., THE BENEFIT OF INCREASING SULFONYLUREA DOSE - RESPONSE, Annals of internal medicine, 119(6), 1993, pp. 538-538
LONG-TERM EFFECTS OF GUAR GUM IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: GROOP PH ARO A STENMAN S GROOP L
Citation: Ph. Groop et al., LONG-TERM EFFECTS OF GUAR GUM IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The American journal of clinical nutrition, 58(4), 1993, pp. 513-518
Risultati: 1-12 |